Scholars assumed that olfactory impairments might reflect the onset of AD, amnestic mild cognitive impairment (MCI), and the presence of amyloid-β (Aβ) and tau pathology (79, 81–86). This evidence concerns the gene MAPT and Alzheimer disease.